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ABSTRACT 
 
Excessive Cl
-
 secretion is the driving force for secretory diarrhea. 17-estradiol has been 
shown to inhibit Cl
-
 secretion in rat distal colon through a nongenomic pathway. We 
examined whether 17-estradiol inhibits Cl- secretion in an animal model of secretory 
diarrhea and the downstream effectors involved. The effect of 17-estradiol on cholera toxin 
and heat-stable enterotoxin induced Cl
-
 secretion in rat colonic mucosal sheets was studied by 
current-voltage clamping. Selective permeabilization of apical or basolateral membranes with 
amphotericin B or nystatin was used to isolate basolateral K
+
 channel and apical Cl
-
 channel 
activity respectively. 17-estradiol dose-dependently inhibited secretory responses to both 
toxins with IC50 values of approximately 1 nM. This effect was female-gender specific, with 
no inhibition observed in male tissues. 17-estradiol responses were insensitive to the pure 
anti-estrogen ICI 182,720. 17-Estradiol exerted its effects downstream of enterotoxin-
induced production of second messengers (cAMP and cGMP) but was dependent on PKC 
activation. In nystatin-permeabilized tissues, apical Cl
-
 currents were unaffected by 17-
estradiol treatment while basolateral K
+
 current was profoundly inhibited by the hormone. 
This current was sensitive to the specific KCNQ1 channel inhibitors chromanol 293B and 
HMR-1556.  In conclusion, 17-estradiol inhibits enterotoxin-induced Cl- secretion via a 
PKC-dependent mechanism involving inhibition of basolateral KCNQ1 channels. These 
data elucidate mechanisms of 17-estradiol inhibition of Cl- secretion induced by 
enterotoxins in intestinal epithelia, which may be relevant for the treatment of diarrheal 
diseases. 
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Keywords: estrogen, KCNQ1 channels, chloride secretion, colonic epithelium, secretory 
diarrhea, enterotoxin. 
 
1. Introduction 
The generation of the electrochemical driving force required for Cl
-
 secretion by 
colonic crypt epithelial cells depends on their ability to accumulate intracellular Cl
-
 ions to 
concentrations greater than their electrochemical equilibrium [1, 2]. Cl
-
 enters the cell across 
the basolateral membrane through the activity of the Na
+
-K
+
-2Cl
-
 cotransporter (NKCC1).  
which in turn, is driven by a strong inwardly directed electrochemical Na
+
 gradient 
established by the basolaterally located Na
+
-K
+
-ATPase. In order to maintain the membrane 
potential at rest and during Cl
-
 secretion, K
+
 must be recycled out of the cell across the 
basolateral membrane [3]. In rat distal colonic epithelia, which is a widely used animal model 
for the study of intestinal Cl
-
 secretion, the basolateral K
+
 conductance is formed by at least 
two different types of K
+
 channels, one activated by Ca
2+
-mobilizing secretagogues and the 
other by cAMP-dependent agonists [4, 5]. Several studies have revealed the latter to be 
KCNQ1, a low-conductance (1-3 pS) basolateral K
+
 channel which is activated during 
cAMP-stimulated Cl
-
 secretion and inhibited by chromanol 293B and HMR-1556 [6, 7]. 
 New insights into the role of basolateral membrane K
+
 channels in regulating 
intestinal Cl
-
 secretion have come from studies of the rapid antisecretory effect of steroid 
hormones, such as aldosterone and 17-estradiol. Previous studies have shown that 
physiological concentrations of 17-estradiol rapidly increase intracellular Ca2+ concentration 
[8, 9], stimulate protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) activity 
[10], and modulate several K
+
 conductances in mammalian colonic epithelia [11]. We have 
also reported that 17-estradiol rapidly inhibits basal and forskolin-stimulated Cl- secretion in 
rat distal colonic epithelium through inhibition of basolateral KCNQ1 channels [12,13]. 
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 4 
These rapid responses to 17-estradiol are insensitive to inhibitors of transcription or 
translation and depend on activation of PKCδ. At the same time, 17-estradiol stimulates an 
ATP-sensitive basolateral K
+
 conductance involved in Na
+
 absorption. These findings suggest 
that the nongenomic effects of 17-estradiol in the intestine lead to a rapid decrease in 
epithelial secretory capacity while increasing the potential for Na
+
 absorption [14, 15]. 
Cl
-
 secretion from the intestinal crypt is thought to play a major role in secretory 
diarrhea of several etiologies [16]. Diarrheal diseases continue to be a major cause of 
morbidity and mortality in children and elderly people throughout the world. Oral rehydration 
therapy remains the mainstay of treatment for diarrhea [17]. However, in recent years 
significant effort has been made in the search for antisecretory drugs that will directly inhibit 
secretory processes within the enterocytes [18-20]. As in all secretory epithelia, the channels 
and transporters of the crypt epithelial cell must operate in concert to achieve vectorial ion 
transport. Therefore, blockade of specific basolateral K
+
 conductance would be expected to 
inhibit the Cl
-
 secretory process. 
In rat distal colon rapid 17-estradiol-induced stimulation of intracellular Ca2+ occurs 
via a cholera toxin-sensitive Gαs-coupled membrane receptor distinct from the classical 
estrogen receptor [21]. Whether 17-estradiol may interfere with cholera toxin (CT) and 
heat-stable entrotoxin from E. coli (STa) induced Cl
-
 secretion is unknown. Using the short 
circuit current (ISC) technique to measure transepithelial ion transport, we tested the ability of 
17-estradiol to inhibit Cl- secretion induced by CT and STa in rat distal colon. In addition, 
we explored potential cell signaling mechanisms and ion transporter targets involved in the 
antisecretory action of 17-estradiol while Cl- secretion was being stimulated by these 
bacterial toxins. 
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2. Experimental 
2.1. Materials 
All regents were purchased from Sigma-Aldrich (Dublin, Ireland) unless stated. Trans-
N-[6-cyano-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-N-methyl-
ethanesulfonamide (chromanol 293B) and 7α,17β-[9-[(4,4,5,5,5-
pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol (ICI 182,780) were 
purchased from Tocris (Avonmouth, UK). Cholera toxin, rottlerin, clotrimazole, iberiotoxin, 
apamin and 2,2',3,3',4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanol
 
dimethyl ether (HBDDE) 
were obtained from Calbiochem (Nottingham, UK). Anti PKCα and anti phospho-Thr638-
PKCα antibodies were obtained from Upstate (Dublin, Ireland). The ECL plus 
chemiluminescent detection system
 
was from Amersham Biosciences (Little Chalfont, UK) 
and Bradford
 
reagent from Bio-Rad (Hemel Hempstead, UK). 1-[(2-
chlorophenyl]diphenylmethyl]-1H-pyrazole (TRAM-34) was kindly provided by Dr. Heike 
Wulff (University of California at Irvine, CA). (3R,4S)-(+)-N-[3-hydroxy-2,2-dimethyl-6-
(4,4,4-trifluorobutoxy)-chroman-4-yl]-N-methylethane-sulfonamide
 
 (HMR-1556) was 
provided by Dr. Uwe Gerlach (Aventis Pharma,
 
Frankfurt-am-Main, Germany). 
 
2.2. Tissue preparation 
Following anesthesia Sprague-Dawley rats (300-350 g) were killed by cervical 
dislocation. Cervical smears were obtained from female rats and the estrous cycle stage was 
determined, all female rats were used at the estrus stage. The distal colon was removed and 
fecal contents were rinsed off and the sub-mucosal layers were removed by blunt dissection. 
Colonic crypts were isolated for biochemical studies using the calcium chelation technique, 
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 6 
as previously described [8] while sheets of colonic mucosa were used for short-circuit current 
measurements. The Ethics Committee of the Royal College of Surgeons in Ireland approved 
all animal procedures. 
 
2.3. Electrophysiology 
Colonic epithelia were mounted in modified Ussing chambers (Physiologic 
Instruments, San Diego, CA, USA) on inserts exposing and area of 0.5 cm
2
. Transepithelial 
potential difference
 
was clamped to zero using an EVC-4000 voltage-clamp apparatus (World 
Precision Instruments, UK). The transepithelial ISC was recorded using Ag-AgCl electrodes in 
3M KCl agar bridges as previously described [12, 13].
 
All preparations were allowed to 
equilibrate for 30-45 min before the experiments were performed. Amiloride 50 M was 
added to the apical bath in all experiments to block electrogenic Na
+
 absorption. The ISC was 
defined as positive for anion flow from the basolateral to apical chamber. 
To investigate the activity of basolateral K
+
 channels in isolation, the apical 
membrane was permeabilized by addition of 10 M amphotericin B in an apical-to-
basolateral K
+
 gradient (80:5 mM), while the Na
+
 concentration was maintained at 25 mM on 
both sides of the monolayers as previously described [13]. Ouabain (1mM) was added to the 
basolateral bath to inhibit Na
+
-K
+
-ATPase. The resulting ISC
 
is due to the movement of K
+
 
through channels at the basolateral membrane (IK). 
To evaluate apical membrane Cl
-
 conductance, tissues were permeabilized by 
basolateral addition of nystatin (200 µg/ml) in the presence of an apical-to-basolateral
 
(126:6 
mM) Cl
-
 gradient (sodium gluconate substituted for NaCl in the serosal
 
medium). Because the 
cystic fibrosis transmembrane conductance
 
regulator (CFTR) protein will conduct Cl
-
 in 
either direction, the Cl
-
 concentration gradient was set to drive Cl
-
 movement from the apical 
to the basolateral side of the epithelia
 
to eliminate the contributions of NKCC1 and Na
+
-K
+
-
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ATPase to the ISC. Under these conditions, the ISC
 
represents the Cl
-
 current (ICl) as Cl
-
 moves 
down its concentration gradient through Cl
-
 channels in the apical membrane. 
 
2.4. Protein kinase C activation 
To evaluate the effect of 17β-estradiol on PKC activity the level of serine-638 
autophosphorylation in PKCα was measure as an index of kinase activation. Briefly, isolated 
distal colonic crypts resuspended in Krebs solution were treated with drugs for the indicated 
time points. The samples were then immediately centrifuged for 30 s at 4 °C at 4,000 x g, and 
the supernatant removed. Cells were lysed by hypotonic shock on ice for 45 min (lysis buffer: 
20 mM Tris, pH 7.4, 0.5% Nonident P-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 
leupeptin 1 μg/μl, 500 mM dithiothreitol, 5 mM phenylmethylsulfonyl fluoride, protease 
inhibitor cocktail  (Roche Applied Science) and phosphatase inhibitors). Following 
incubation the samples were clarified at 12,000 x g for 10 min. The cleared supernatant was 
collected and the protein content was quantified by the Bradford method. For activation 
assays 50 μg of sample were combined with 2× Laemmli buffer, boiled at 95 °C for 5 min, 
and spun at 12,000 x g for 2 min. Western blot analysis was carried out as standard. Protein 
was transferred to polyvinylidene difluoride membranes, blocked in 1× TBS with Tween 
(0.3%) (1× TBST) and 5% nonfat dry milk for 1 h. Membranes were incubated with the 
appropriate primary antibody (phospho-Thr638-PKCα 1:1000 or PKCα 1:1000) overnight at 
4 °C and incubated for 1 h at room temperature with the appropriate secondary antibody. 
Membranes were washed in 1× TBST 0.3% three times for 15 min. Bands were detected 
using autoradiographic film and chemiluminescence.  
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2.5. Statistical analysis 
Statistical analysis of the data was obtained by analysis using t-test for analysis 
between two groups. One-way ANOVA and Tukeys post-hoc test was used for multiple 
analyses of groups. P-values of 0.05 and less were considered to be significant. Data are 
expressed as means  SEM unless specifically stated to be from a representative experiment. 
Number of samples (n) refers to the number of animals used in each experiment. 
 
3. Results 
3.1. 17-estradiol inhibits Cl- secretion evoked by bacterial toxins 
Several species of bacteria induce secretory diarrhea, including Vibrio cholerae and 
Escherichia coli. These pathogens do so by alteration of ion transport, disruption of tight 
junctions, and activation of an inflammatory response. We first set out to examine the effect 
of 17-estradiol on intestinal secretion elicited by CT and STa. Addition of 1 g/mL CT to 
the luminal side of the epithelia resulted in a sustained increase in ISC (Fig. 1A). This effect 
occurred with a delay of approximately 90 min before the current slowly increased, usually 
reaching a plateau in 2 hours. In contrast, apical addition of 50 ng/mL STa induced an almost 
instantaneous and sustained increase in ISC (Fig. 1C). Physiological concentrations (0.1 – 10 
nM) of 17-estradiol reduced the secretory response to both toxins in a concentration-
dependent manner (Fig. 1B, 1D) with maximal inhibition observed at 10 nM (58 ± 5 % 
inhibition of STa-induced ISC, n = 8; 50 ± 4 % inhibition of CT-induced ISC, n = 8). The half-
maximal concentration for the antisecretory effects of 17-estradiol (EC50) was 0.7  0.2 nM 
for STa-induced secretion and 0.9  0.3 nM for CT-induced secretion (n = 8). When 17-
estradiol (10 nM) was added to tissues in the absence of toxins, the ISC significantly 
decreased by 7 ± 2 μA/cm2 (P < 0.05, n = 8) (Fig. 2A). Preincubation for 15 min with 17-
estradiol profoundly inhibited the subsequent CT or STa activated ISC response (Fig 2A, 2B). 
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These responses were ~60 % less than that observed in control tissues (Fig. 2B). The 
antisecretory effect of 17-estradiol on enterotoxin-induced secretion was observed to be 
female gender specific. Inhibition of enterotoxin-induced currents was only observed in 
colonic tissues from female rats with no significant response in male tissues (Fig. 3) even at 
concentrations of 17-estradiol as high as 100 nM. 
 
3.2. Signaling pathways involved in the antisecretory response to 17-estradiol 
Previous data from our laboratory suggest that the rapid onset of the 17-estradiol 
antisecretory effect is incompatible with a genomic signaling pathway associated with 
estrogenic action [8-13]. In this study, the effects of 17-estradiol on enterotoxin-induced Cl- 
secretion were found to be insensitive to inhibitors of transcription or translation such as 
actinomycin D (5 M) and cycloheximide (20 M) respectively (data not shown), confirming 
the nongenomic nature of this rapid antisecretory effect of 17-estradiol. The inhibitory 
effect of 17-estradiol on STA or CT induced secretion was not prevented by 30 min pre-
incubation with the pure antiestrogen ICI 182,780 (10 µM) suggesting a signaling pathway 
independent of nuclear estrogen receptors (Fig. 4A, 4B). The selectivity of 17-estradiol 
action was tested by treating colonic epithelia with other sex steroids such as testosterone, 
progesterone and the biologically inactive 17-estradiol. We found that none of the other 
steroids tested had the ability to mimic the antisecretory actions of 17-estradiol on either 
STa or CT induced secretory responses (Fig. 4C, 4D). 
CT induces intestinal secretion via an excessive increase in intracellular cAMP, due to 
irreversible activation of adenylyl cyclase, while STa enhances intracellular cGMP 
production, leading to activation of protein kinase GII (PKGII) [16]. Since our data indicate 
that the inhibitory effect of 17-estradiol is independent of the second messenger pathway 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 10 
involved, we further investigated whether the target of 17-estradiol occurs proximal or distal 
to cyclic nucleotide generation. Therefore, electrogenic Cl
-
 secretion was induced by means 
of the cell permeable nucleotide analogs, 8Br-cAMP (1 mM) or 8Br-cGMP (1 mM). These 
compounds induced rapid and sustained increases in ISC and in both cases, the currents were 
reduced by 17-estradiol (Fig. 5). Thus, the antisecretory effect of 17-estradiol on Cl- 
secretion appears to occur distal to the synthesis of either cAMP or cGMP. 
We have previously demonstrated that 17-estradiol induced a female-specific rapid 
increase in PKC activity, measured as kinase autophosphorylation (13). Pretreatment of the 
crypts with 10 µM rottlerin, a concentration known to selectively inhibit PKC [23] 
abolished the hormone-induced activation of PKC (13). Here we found that the inhibitory 
action of 17-estradiol on STa induced secretion was abolished after 15 min pre-incubation 
with 10 µM rottlerin (Fig. 6A). We also found that treatment of colonic crypts with 17-
estradiol (10nM) had no effect on PKC activity measured as kinase autophosphorylation 
(data not shown). Moreover, the PKC inhibitor HBDDE (100 µM) failed to prevent the 
effect of 17-estradiol on enterotoxin-induced secretion (Fig. 6B). These results indicate that 
the rapid activation of PKC by 17-estradiol is required for inhibition of Cl- secretion 
induced by enterotoxins. 
Several studies have shown that transactivation of the epidermal growth factor 
receptor (EGFR) reduces the extent of Gq-protein coupled receptor induced Cl
-
 secretion 
while increasing 
 
secretory responses mediated by Gs-protein coupled receptors in colonic 
epithelial cells [24, 25]. Recent evidence has also suggested EGFR can be transactivated by 
steroid hormones in a nongenomic fashion [26-29]. To determine if transactivation
 
of the 
EGFR plays a role in antisecretory effect of 17-estradiol, we examined the effects of the 
EGFR inhibitor, tyrphostin
-
AG1478, on ISC responses to forskolin (10 µM). Pretreatment 
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with tyrphostin
-
AG1478 (1 µM), failed to prevent the antisecretory effect of 17-estradiol on 
ISC responses induced by forskolin. Control ISC responses to forskolin were
 
32.8 ± 5.5 µA/cm
2
 
compared with 17.3 ± 4.5
 
µA/cm
2
 after 17-estradiol treatment and 25.1 ± 5.1 in tyrphostin-
pretreated cells (n = 4; P = 0.072). 
 
3.3. Effect of 17-estradiol on ion channel activity 
Apical membrane Cl
-
 channels – Nystatin, added to the basolateral bathing solution of 
control tissues, increased the Cl
-
 current (ICl) by 10 ± 3 μA/cm
2
 (n = 7). This likely reflects an 
unmasking of a constitutively active apical Cl
-
 conductance. Subsequent addition of CT and 
STa increased the ICl to 82 ± 5 μA/cm
2
 (n = 4) and 56 ± 4 μA/cm2 (n = 4), respectively. Pre-
incubation with 17-estradiol (10 nM) for 15 min had no significant effect on either the 
nystatin or enterotoxin + nystatin induced ICl (Fig. 7A) (nystatin + 17-estradiol 8 ± 5 
μA/cm2; CT + nystatin + 17-estradiol 77 ± 6 μA/cm2; STa + nystatin + 17-estradiol 51 ± 5 
μA/cm2; P > 0.05, n = 4) . These results indicate that 17-estradiol neither inhibits the basal 
activity of apical Cl
-
 channels nor of enterotoxin stimulated apical Cl
-
 channels. 
Basolateral membrane K
+
 channels – When amphotericin B was added to the apical 
bath in the presence of an apical to basolateral directed K
+
 gradient (80:5 mM) and ouabain 
(1 mM) in the basolateral solution, the K
+
 dependent current (IK) immediately began to 
increase and reached maximal levels within 15 min (from 6 ± 2 to 81 ± 15 μA/cm2, n = 6). 
The IK decreased rapidly by ~60% (to 27 ± 5 μA/cm
2
, n = 6) following addition of 17-
estradiol at the peak of the amphotericin-induced response (Fig. 7B). Pretreatment of colonic 
epithelia with rottlerin for 15 min before addition of amphotericin B did not modify the 
increase in IK induced by the ionophore but prevented the inhibition of IK by 17-estradiol 
(Fig. 7B). Thus PKCδ activity is required for estrogen inhibition of basolateral membrane K+ 
channel activity. 
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In order to functionally identify the K
+
 channel involved we tested the effects of 
selective K
+
 channel inhibitors on the basal and enterotoxin-stimulated IK. As shown in Fig. 
8A, when tissues were pretreated with 17-estradiol (10 nM) for 15 min., the basal IK was 
reduced by ~65 % of control values (81 ± 15 compared to 25 ± 2 μA/cm2, n = 6). The IK 
currents remaining after amphotericin B treatment alone and after estrogen treatment were 
largely inhibited by basolateral application of chromanol 293B (50 µM), a KCNQ1 channel 
inhibitor.   Basolateral addition of BaCl2 (2 mM) or the more selective KCNQ1 inhibitor 
HMR-1556 (10 M) also produced an inhibition of the spontaneous IK similar to that of 
chromanol 293B (Fig. 8B). Other specific K
+
 channel inhibitors (of large (BK) and small 
(SK) conductance, Ca
2+
-dependent K
+
 channels) such as iberiotoxin (BK, 200 nM), apamin 
(SK, 500 nM) and TRAM-34 (KCNN4, 500 nM) did not affect IK (Fig. 8B). These results 
indicate that the basolateral membrane IK is largely generated by a K
+
 conductance with a 
pharmacological profile similar to KCNQ1 channels and this channel is a target of 17-
estradiol. 
 Pretreatment with CT significantly increased IK to 127 ± 10 μA/cm
2
 (n = 3, P < 0.01) 
(Fig. 8C), a result in line with the well known stimulatory effect of cAMP on basolateral 
KCNQ1 channels via a PKA dependent pathway [7]. In contrast, pretreatment with STa had 
no significant effect on IK (85 ± 8 μA/cm
2
; n = 3, P = 0.24) (Fig. 8C) suggesting that the 
cGMP/PKG pathways does not stimulate KCNQ1 channels but rather acts on the apical Cl
-
 
conductive pathway. Addition of 17-estradiol decreased the CT-stimulated IK and also 
inhibited the basal IK in the presence of STa (Fig. 8C). Both KCNQ1 and KCNN4 channels 
are functionally expressed in the female rat colon but it appears from our results that only the 
KCNQ1 channel is the target for estrogen inhibition of basolateral membrane K
+ 
current.  In 
order to determine the relative roles of these channels in sustaining the toxin-induced Cl
-
 
secretion, we tested the responses of the CT and STa-induced ISC to clotrimazole and 
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chromanol 293B. As shown in Fig. 8D, only the KCNQ1 channel inhibitor produced a 
marked inhibition of enterotoxin-induced Cl
-
 secretion whereas clotrimazole (10 μM), a 
specific inhibitor of Ca
2+
-dependent KCNN4 channels had no effect on Cl
-
 secretion. Taken 
together, these results demonstrate the key role of KCNQ1 channels in mediating 
enterotoxin-induced secretion and the targeting of this channel by 17-estradiol to affect an 
antisecretory response.  
 
4. Discussion 
The initiation of the secretory response induced by E. coli and V. cholerae is 
dependent on toxin binding to receptors on the surface of intestinal enterocytes. After 
binding, cyclic nucleotides levels are increased, which ultimately lead to secretion by crypt 
cells of fluid and electrolytes into the intestine lumen, and watery diarrhea. Any substance 
capable of decreasing net fluid secretion, by either inhibiting the secretory process or by 
enhancing fluid absorption, is a potential antidiarrheal drug. Oral rehydration therapy has a 
significant impact on morbidity and mortality of patients with acute diarrhea; however, oral 
rehydration therapy does not interfere with the secretory process nor diminish diarrhea [17]. 
Therefore, new, safe and more effective antisecretory drugs are being sought. Several 
inhibitors of ion transport and intestinal secretion have been described. In animal models, 
loperamide and berberine inhibit secretion by CT [30,31]. Berberine, chlorpromazine, and 
indomethacin also reduce secretion induced by STa [31,32]. Despite the efficacy of these 
drugs in animal models, none are routinely used in humans because of adverse side effects of 
the high concentrations required for efficacy. 
In this study, the sex steroid 17-estradiol rapidly decreased Cl- secretion induced by 
CT and STa; two of the major causes of secretory diarrhea in humans. Physiological 
concentrations of 17-estradiol reduced basal Cl- secretion, prevented CT and STa 
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stimulation of Cl
-
 secretion and rapidly decreased Cl
-
 secretion pre-stimulated by these toxins 
in the female rat distal colon. These results provide the first evidence for an antisecretory 
effect of 17-estradiol on enterotoxin-induced Cl- secretion in the intestine, and point to a 
potential role for manipulation of 17-estradiol-dependent signaling pathways and ion 
transporter targets in the treatment of secretory diarrheas. 
The rapid antisecretory responses to 17-estradiol are likely to be mediated by a novel 
receptor protein in colonic epithelial cells [21,33]. This is supported by the acute onset of the 
effect and by experiments, which demonstrated that pre-incubation with inhibitors of 
transcription and translation, or the pure antiestrogen ICI 182,170 [34] did not prevent the 
antisecretory effect of 17-estradiol. Although several studies have suggested that rapid 
effects of 17-estradiol are mediated by a novel estrogen receptor, the molecular identity of 
this receptor remains elusive. Over the last decade, the G-protein coupled receptor-30 protein 
(GPR30) [35] has emerge as a candidate receptor for the non-genomic effects of 17-
estradiol in several tissues and cell lines. The role of GPR30 in mediating the anti-secretory 
effects of 17-estradiol in female rat distal colon will be the subject of future studies, 
however, the lack of inhibition by ICI182,720 suggests a different signaling pathway. 
The effect of estrogen to inhibit secretion displays sexual dichotomy and was only 
observed in colonic tissue isolated from female rats. In female rat colonic crypts, 17-
estradiol stimulates a rapid increase in intracellular Ca
2+
, PKA and PKC activity while having 
no effect on these second messengers in male colon [8, 10]. Previous studies from our 
laboratory have shown that in a cell free system assay, 17-estradiol can directly activate the 
PKC and PKC isoforms through binding to their C2 domain [10,22]. However, we have 
shown that activation of PKC but not PKC is required for 17-estradiol to reduce Cl- 
secretion and that female colonic epithelia express significantly higher levels of these PKC 
isoforms compared to males [13]. Since estrogens can freely diffuse across cell membranes, it 
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is plausible that PKC may be directly activated by 17-estradiol independent of other 
signalling pathways. Thus, PKC may constitute a novel receptor for estrogens. Therefore, 
the mechanism for gender specificity of 17-estradiol antisecretory action may be related to 
PKC expression levels or differences in the K+ channel protein components. Alternatively, 
colonocytes from male animals may not express the most proximal component of the 17-
estradiol nongenomic signaling pathway, the putative novel estrogen receptor. Up to date 
there is no PKC specific inhibitors, therefore our study relied on using the selective PKC 
inhibitor rottlerin. However, recent studies have shown that this inhibitor is capable of 
inhibiting other protein kinases [36]. Thus, our results must be analyzed from that 
perspective. Unfortunately, primary tissues are extremely hard to transfect with iRNA in 
order to inhibit the expression of PKC. 
The molecular target for the 17-estradiol antisecretory effect appears not to be CFTR 
or other apical Cl
-
 channels but rather the K
+
 channel responsible for K
+
 recycling at the 
basolateral membrane. Pharmacological characterization of this K
+
 current suggests that it is 
generated by KCNQ1 channels. KCNQ channels are a family of voltage-dependent, cAMP- 
and Ca
2+
-dependent K
+
 channels, first characterized in cardiac tissue [6,7,37]. In colonocytes, 
the KCNQ1 isoform is localized at the basolateral membrane and participates in K
+
 recycling 
required for Cl
-
 secretion induced by cAMP [1,6,38,39]. In colonic epithelia KCNQ1 is 
coexpressed with the regulatory KCNE3 subunit. Association of KCNQ1 with KCNE3 at the 
basolateral membrane of colonocytes produces constitutively open channels that regulate 
potassium recycling required to maintain the driving force for chloride secretion[ 40]. Studies 
on KCNE3 knockout mice have shown that decreased expression of this subunit impairs the 
secretory capacity in colon and trachea [41]. Experiments using chromanol 293B, as an 
inhibitor of KCNQ1 channels have shown that this compound can completely block cAMP-
induced Cl
-
 secretion. Our data shows that basolateral KCNQ1 currents are stimulated by the 
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cAMP-dependent CT but insensitive to stimulation by the cGMP-dependent STa 
secretagogues. Although modulation of basolateral KCNQ1 channel activity by 17-estradiol 
may underlie the inhibition of basal and enterotoxin-stimulated Cl
-
 secretion, the hormone 
does not completely inhibit the enterotoxin-induced Cl
-
 secretion but rather reduces it by up 
to 60%. Recent studies [42] using the HMR-1556 compound, a more selective inhibitor of 
KCNQ1 [43,44], have shown that KCNQ1 channels are not essential for activation of Cl
-
 
secretion and contribute up to 50 % of K
+
 recycling during cAMP-induced secretion. 
Pretreatment of colonic epithelia with the PKC inhibitor rottlerin suppressed the inhibitory 
effect of 17-estradiol on basolateral K+ currents. Therefore, we propose that 17-estradiol 
decreases basal and enterotoxin-induced Cl
-
 secretion by activating PKC, which 
phosphorylates basolateral KCNQ1 channels to reduce K
+
 recycling and thereby decreases 
the electrochemical gradient required for Cl
-
 secretion [13]. In agreement with these findings, 
Reenstra has shown that the phorbol ester PMA inhibits the basolateral K
+
 conductance of 
T84 cells and that this effect reduces transepithelial Cl
-
 secretion [45]. The precise 
mechanism through which 17-estradiol-induced phosphorylation of basolateral KCNQ1 
channels inhibits channel activity in rat colonic crypts is unknown and will be an important
 
goal of future studies. One possibility to be considered is reduction of channel number at the 
plasma membrane. 
Our finding that 17-estradiol has a marked inhibitory effect on basolateral KCNQ1 
channels in rat colonic crypts highlights this component of
 
the intestinal Cl
-
 secretory process 
as a target for new antidiarrheal
 
strategies. Identification of the mechanism of hormonal 
regulation of basolateral K
+
 channels in colonic epithelia and
 
a better understanding of the 
signaling processes involved may
 
provide a basis for the development of new antisecretory 
drugs
 
with greater potency and
 
specificity. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 17 
Several groups have explored the selective blockade of basolateral K
+
 channels as a 
means of regulating epithelial Cl
-
 secretion. The antifungal antibiotic, clotrimazole,
 
has also 
been shown to prevent fluid and electrolyte secretion
 
in rabbit and mouse intestine triggered 
by Ca
2+
- and cAMP-mediated agonists via specific inhibition of basolateral
 
K
+
 conductances 
[46]. Furthermore, levamisole and other phenylimidazothiazoles
 
inhibit Ca
2+
- and cAMP-
activated Cl
-
 secretion in T84 cell monolayers and isolated human distal colon,
 
apparently by 
blocking basolateral K
+
 channels [47]. 
In the present study, we have demonstrated that 17-estradiol can rapidly inhibit 
enterotoxin-induced Cl
-
 secretion in female distal colonic epithelium. This suggests 17-
estradiol may also alter colonic ion transport during high estrogen states such as pregnancy 
and certain phases of the menstrual cycle [48,50], and during use of oral contraceptives [49] 
and estrogen treatment [50,51]. A molecular target of the anti-secretory effects of estrogen 
has been identified as the basolateral KCNQ1 K
+
 channel in rat colon [52]. This channel has 
been shown to be rate-limiting for secretion in colon and airway epithelia [53]. Moreover, 
estrogen enhances amiloride-sensitive Na
+
 absorption in mouse renal cortical collecting duct 
and distal colon (Robles, Flores, Thomas and Harvey, unpublished data).  Therefore, we 
conclude that the ability of 17-estradiol to limit secretion and enhance absorption in the 
major organs regulating whole body fluid and electrolyte balance [51] may contribute in the 
well-known fluid retentive properties of this hormone. 
The results of this study have three major implications. Firstly, it demonstrates that 
estrogen is protective in the female against enterotoxins causing secretory diarrhoea. This 
may have an evolutionary advantage to protect reproductive females against fluid loss during 
the implantation window. Secondly, it highlights the key role of the KCNQ1 channel in 
sustaining enterotoxin-induced secretion and that this channel is the ion transport target 
underpinning the rapid inhibitory effects of 17-estradiol on Cl- secretion. Finally, it offers a 
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cellular and molecular explanation for the whole body salt and water retention responses in 
high estrogen states.  
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FIGURE LEGENDS 
Figure 1. Effect of 17-estradiol on enterotoxin-induced Cl- secretion. (A, C). Representative 
recordings showing the effect of cholera toxin CT (1 g/mL) and heat stable enterotoxin STa 
(50 ng/mL) pretreatment respectively on ISC in female rat distal colonic epithelium followed 
by application of 10 nM 17-estradiol (red line) or a methanol vehicle 0.01 % (blue line). (B, 
D) Mean  SEM change in ISC after treatment with different 17-estradiol concentrations 
following exposure to cholera toxin or STa Values were measured after maximal inhibition 
was achieved by each dose of 17-estradiol and are compared to parallel vehicle controls 
(methanol) from the same animal. Maximal inhibition was achieved after a period of 30-45 
min after 17-estradiol treatment. The reported values are the mean of 5 min recording at the 
plateau of the response.  (n = 8 for each group]. * P < 0.05, ** P < 0.01 compared to control. 
 
Figure 2. 17-estradiol pretreatment inhibits enterotoxin-induced Cl- secretion. (A) 
Representative recording of the effect of 15 min pretreatment with 10 nM 17-estradiol (red 
line) on the STa-induced Cl
-
 secretion compared to a vehicle control (blue line). (B) Mean  
SEM (n = 8 for each group] change in ISC measured at the peak of enterotoxin-induced 
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secretion following 17-estradiol (10 nM) pretreatment and compared to vehicle control (** 
P < 0.01 compared to control). 
 
Figure 3. Effect of 17-estradiol on enterotoxin-induced Cl- secretion is gender specific. (A) 
Representative recording of the effect of 10 nM 17-estradiol on STa-induced ISC in male 
(blue line) and female (red line] rat colonic epithelia. (B) Gender specificity of 17-estradiol 
(10 nM] inhibition of enterotoxin-induced secretion in female (black bars] compared to male 
(grey bars] rat colonic tissues. Values are mean  SEM of n = 6 animals for each group, (** P 
< 0.01). 
 
Figure 4. Effect of antiestrogen and other sex steroid hormones on enterotoxin-induced Cl
-
 
secretion. (A, B) Mean  SEM (n = 6] change in total ISC caused by STa and CT in control 
conditions, in the presence of ICI 182,780 (10 M], and ICI 182,780 plus 17-estradiol (10 
nM) in female rat distal colon. (C, D) Effect of steroid hormones on STa- and CT-induced 
secretion respectively. Mean  SEM (n = 6) change in ISC caused by enterotoxin in control 
conditions, in the presence of 17-estradiol (10 nM), 17-estradiol (10 nM), progesterone (10 
nM) and testosterone (10 nM) (* P < 0.05, ** P < 0.01 compared to control). 
 
Figure 5. Effect of 17-estradiol on Cl- secretion induced by cAMP (grey bars) and cGMP 
(black bars) analogs. Mean  SEM (n = 6) change in total ISC caused by 8Br-cAMP (1 mM) 
and 8Br-cGMP (1 mM) in control conditions and in the presence of 17-estradiol (10 nM) in 
female rat distal colon ( * P < 0.05 compared to control). 
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Figure 6. Role of PKC isoforms on the antisecretory effect of 17-estradiol. (A) 
Representative recording of the effect of Rottlerin (blue line] on the 17-estradiol 
antisecretory response compared to preincubation with a vehicle control (red line]. (B) Mean 
 SEM (n = 6) change in ISC caused by pre-
M) and PKC inhibitor HBDDE (100 M) on the antisecretory effect of 17-estradiol (10 
nM) in STa-stimulated colonic epithelia (** P < 0.01 compared to control). 
 
Figure 7. Effects on estrogen on apical Cl
-
 and basolateral K
+
 currents in antibiotic-
permeabilized colonic epithelia.  (A) The basolateral membrane was permeabilized with 
nystatin and apical chloride currents measured in response to 17-estradiol (10 nM). Estrogen 
had no effects on apical membrane Cl
-
 current. (B) The apical membrane was permeabilized 
with amphotericin B and basolateral membrane K
+
 currents recorded in response to 17-
estradiol (10 nM) in the absence or presence of the PKC inhibitor rottlerin (10 µM). 
Estrogen produced a profound inhibition of basolateral K
+
 current (red line) compared to 
vehicle control (blue line) which was largely prevented by pre-treatment with rottlerin (green 
line). 
 
Figure 8. Effects of K
+ 
channel inhibitors on basolateral K
+
 channel current and the 
antisecretory response to estrogen in the absence or presence of enterotoxins. (A) Effect of 
the KCNQ1 channel inhibitor chromanol 293B on basolateral membrane K
+
 current in 
amphotericin-permeabilized female rat colonic epithelia. Chromanol 293B (50 M) produced 
an almost complete inhibition of IK in the absence of estrogen (blue line) and following pre-
treatment with 17-estradiol (10 nM, red line). (B)  Effect of several specific K+ channels 
inhibitors on IK.  Only the KCNQ1 channel inhibitors, chromanol 293B and HMR-1556 (10 
µM), produced a significant inhibition of IK as did the non-selective K
+
 channel inhibitor 
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BaCl2 (2 mM). Treatment with inhibitors of Ca
2+
-activated K
+
 channels iberiotoxin (200 nM), 
apamin (500 nM) and TRAM-34 (500 nM) had no effect on IK. Values are means ± SEM 
n = 6. ** P < 0.01 vs. control. (C) Effect of 17-estradiol on basolateral K+ currents pre-
stimulated with bacterial enterotoxins. Cholera toxin produced an increase in IK which was 
inhibited by estrogen (E2). Heat-stable enterotoxin had no effect on IK but this current was 
also inhibited by estrogen (10 nM). Values are means ± SEM, n = 4. ** P < 0.01 vs. control. 
(D) Effect of 10 µM clotrimazole (KCNN4 inhibitor) and 50 µM chromanol 293B (KCNQ1 
inhibitor) on transepithelial chloride ion secretion induced by cholera toxin (black bars) or 
STa (grey bars).  Only the KCNQ1 channel inhibitor produced a significant inhibition of the 
enterotoxin-induced secretion (P < 0.01 vs. control DMSO vehicle response) whereas the 
KCNN4 inhibitor had no effect on secretion. 
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